Mianserin Viatris

Mianserin, the active ingredient in Mianserin Viatris, is a tetracyclic antidepressant presented as an oral dosage form for oral use. It is indicated for the treatment of major depressive disorder in adult patients. GNH USA supplies Mianserin Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mianserin is a tetracyclic antidepressant used primarily in the management of depressive disorders. - Major depressive disorder: alleviates depressive symptoms and improves mood in adults. - Depressive episodes associated with major depressive disorder: reduces severity and duration of episodes. - Treatment‑resistant depression (off‑label): may be considered when other antidepressants are ineffective.

Mianserin may cause a range of adverse reactions, which vary in frequency and severity.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Dry mouth: reduced salivation leading to throat discomfort. - Weight gain: increase in body weight over time. - Constipation: difficulty passing stools. - Dizziness: sensation of light‑headedness or unsteadiness. - Increased appetite: heightened desire for food.

Serious or Rare Side Effects: - Agranulocytosis: severe reduction in white blood cells. - Seizures: convulsive episodes, especially at high doses. - Severe hypotension: marked drop in blood pressure. - Cardiac arrhythmia: irregular heart rhythm. - Suicidal ideation: emergence or worsening of suicidal thoughts. - Hepatic dysfunction: abnormal liver enzyme elevations.

Before initiating therapy with Mianserin, several safety considerations should be observed. - Monitor blood pressure: watch for orthostatic hypotension, especially at treatment start. - Assess for suicidal thoughts: evaluate mood changes and suicidal ideation regularly. - Evaluate liver function: perform baseline and periodic liver enzyme tests. - Use caution in the elderly: increased sensitivity to sedation and anticholinergic effects. - Avoid abrupt discontinuation: taper dose to minimise withdrawal symptoms. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Mianserin can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of severe serotonin syndrome. - Central nervous system depressants (e.g., benzodiazepines, barbiturates): enhanced sedation and respiratory depression. - Antihistamines: additive sedative and anticholinergic effects.

Moderate Interactions (Monitor Closely): - Selective serotonin reuptake inhibitors (SSRIs): potential for increased serotonergic activity. - CYP2D6 inhibitors (e.g., fluoxetine, quinidine): may raise Mianserin plasma concentrations. - Alcohol: can intensify CNS depression and dizziness.